-

Lubrizol Announces Lubrizol® CV9660, a Low-SAPS Heavy Duty Solution Covering Multiple Viscosity Grades

CLEVELAND--(BUSINESS WIRE)--Lubrizol, a global leader in additive technology for the transportation industry, has launched Lubrizol® CV9660, a new low-SAPS Heavy Duty lubricant technology that meets higher levels of performance while also delivering a simplified solution for multiple viscosity profiles.

Formulated to address the growing demands for ACEA E8 lubricants in the European market, Lubrizol® CV9660 demonstrates a deep understanding of evolving market needs, leading the development of innovative solutions that meet and advance the latest standards. The new product, which utilizes the renowned performance polymer Lubrizol® 7077, is notable for covering multiple viscosity grades in the Heavy Duty space to meet an array of needs, boosting efficiency and delivering added value.

“Low-SAPS, Heavy Duty lubricants pose a challenge to our customers,” said Alex Brewster, Lubrizol Heavy Duty Product Manager, Europe. “Viscosity grades, base oils, and additive packages all create complexity within the oil marketers’ operations and within the product range itself. In addressing this challenge, we are pleased to have developed a solution with exponential benefits.”

Lubrizol® CV9660 joins a suite of products supporting the diverse needs of the Heavy Duty market and bolsters Lubrizol’s reputation in the industry as a total solutions provider.

Learn more about Lubrizol® CV9660: Innovative Heavy Duty Additive Technology for OEM Hardware Protection. (https://go.lubrizol.com/z5hhpz4g)

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve wellbeing and enhance modern life. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has more than 8,000 employees. For more information, visit www.Lubrizol.com.

Contacts

Sarah Rowley, Regional Marketing Manager, LZA Europe
Sarah.rowley@lubrizol.com

The Lubrizol Corporation



Contacts

Sarah Rowley, Regional Marketing Manager, LZA Europe
Sarah.rowley@lubrizol.com

Social Media Profiles
More News From The Lubrizol Corporation

Lubrizol Hosts First Asia-Pacific Innovation Summit, Unveils Breakthrough Technologies Driving Sustainable Growth

SHANGHAI--(BUSINESS WIRE)--Lubrizol, a global leader in specialty chemicals, today hosted its first Asia-Pacific Innovation Summit in Shanghai. The event brought together more than 150 industry leaders, technical experts, and strategic partners to explore emerging trends in material science, discuss innovation-driven collaboration, and define new pathways for sustainable industry growth. As industries undergo structural transformation and sustainability becomes a defining priority, market deman...

Lubrizol Launches New Zinc-Free Hydraulic Additive for Enhanced Environmental Protection

CLEVELAND--(BUSINESS WIRE)--Lubrizol announces the launch of Lubrizol® AH933ZF, a zinc-free additive package that enables robust performance and user benefits, enabled by innovative Lubrizol science. Zinc-free hydraulic fluids have been increasingly desirable in recent years as regulators, OEMs and other stakeholders seek to minimize potential disruptions in sensitive environmental applications. Lubrizol’s latest innovation meets these needs. Ideal for applications like mining, forestry, marine...

Lubrizol’s Microencapsulated Iron Demonstrates Superior Absorption and Tolerance in Preclinical Study

BARCELONA, Spain--(BUSINESS WIRE)--Lubrizol announces new preclinical findings confirming the superior performance of its microencapsulated iron ingredient, Lipofer™ microcapsules, compared to conventional iron sources. The study, published in Nature, evaluated iron-deficient rats and demonstrated that Lipofer™ microcapsules significantly improved iron absorption and gastrointestinal tolerance—reversing iron deficiency within just 14 days. Iron deficiency anemia (IDA) affects over 2 billion peo...
Back to Newsroom